Zogenix, Inc. Highlights DosePro(R) Needle-Free Delivery System at 2011 AAPS National Biotechnology Conference

SAN DIEGO, May 18, 2011 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) today announced that it presented three posters highlighting its proprietary DosePro® Needle-free Delivery System (DosePro) at the 2011 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Francisco, CA.

MORE ON THIS TOPIC